Chemed Corporation Intrinsic Stock Value – Chemed Corporation Reaches New Heights with Relative Strength Rating Upgrade
December 8, 2023
☀️Trending News
This upgrade signals a welcome boost for Chemed and their continued success in the stock market. With the recent upgrade to their RSR, Chemed is set to reach new heights in the stock market and provide value to its shareholders. The upgrade of Chemed Corporation ($NYSE:CHE)’s RSR is a major step forward for the company and its shareholders.
It signals that the company is on the way up, and that its stock could be a great opportunity for investors. With a strong position in the market and excellent potential for growth, Chemed Corporation is a great place to look for investment opportunities.
Stock Price
On Tuesday, CHEMED CORPORATION stock opened at $577.7 and closed at $576.6, down by 0.4% from its previous closing price of 578.8. Despite this minor dip in price, the company experienced a major milestone when it received an upgrade to its Relative Strength Rating. This new rating indicates that the company has achieved a new level of success, and is set to make even more gains in the future.
Furthermore, this new rating is a testament to the hard work and dedication of CHEMED CORPORATION’s management team and staff as they strive to make the company a leader in its industry. With this new rating, investors can be confident that CHEMED CORPORATION is headed in the right direction and will continue to bring growth and success for its shareholders. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Chemed Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 2.23k | 244.58 | 11.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Chemed Corporation. More…
| Operations | Investing | Financing |
| 321.94 | -68.46 | -88.11 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Chemed Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.56k | 542.84 | 67.92 |
Key Ratios Snapshot
Some of the financial key ratios for Chemed Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 2.5% | 0.2% | 14.5% |
| FCF Margin | ROE | ROA |
| 11.6% | 20.4% | 12.9% |
Analysis – Chemed Corporation Intrinsic Stock Value
At GoodWhale, we have conducted an analysis of the wellbeing of CHEMED CORPORATION. After thorough research and evaluation, we have concluded that the intrinsic value of CHEMED CORPORATION’s stock is approximately $536.4, which has been calculated using our proprietary Valuation Line. At present, CHEMED CORPORATION’s stock is being traded at a price of $576.6, which is a fair price but is slightly overvalued by 7.5% when compared to the intrinsic value of its stock. More…
Peers
The competition between Chemed Corp and its competitors is fierce. Chemed Corp is the largest provider of hospice care in the United States, and its competitors are Brookdale Senior Living Inc, Encompass Health Corp, and Pennant Group Inc. All of these companies are vying for a share of the $15 billion hospice market. Chemed Corp has a lot of experience in the hospice industry, and its competitors are trying to catch up.
– Brookdale Senior Living Inc ($NYSE:BKD)
Brookdale Senior Living Inc is a company that owns and operates senior living communities. As of 2022, the company had a market cap of 837.09M and a ROE of 10.52%. The company offers a variety of services for seniors, including independent living, assisted living, memory care, and skilled nursing.
– Encompass Health Corp ($NYSE:EHC)
Encompass Health Corporation is a provider of rehabilitation and wellness services. The company operates through two segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides rehabilitation services on an inpatient basis to patients recovering from illnesses and injuries. The Home Health and Hospice segment provides home health services to patients recovering from illnesses and injuries. Encompass Health Corporation was founded in 1985 and is headquartered in Birmingham, Alabama.
– Pennant Group Inc ($NASDAQ:PNTG)
The Pennant Group, Inc. is a provider of healthcare services for senior living communities and post-acute care centers in the United States. The company operates through three segments: Senior Living, Home Health, and Hospice. The Senior Living segment offers a range of services, including skilled nursing, assisted living, independent living, and memory care services. The Home Health segment provides home health services, such as skilled nursing, physical therapy, occupational therapy, and speech therapy. The Hospice segment offers hospice services, including nursing care, social work services, chaplain services, and bereavement counseling.
Summary
CHEMED Corporation has recently been given a relative strength rating upgrade by an investment analysis firm. This shows that the stock of CHEMED Corporation is performing well and is surpassing certain thresholds in terms of its current market value. For investors, this is an exciting development as it may indicate that investing in CHEMED Corporation could be a profitable decision. There are still risks to consider when investing in any stock, so investors should conduct their own research to gain a better understanding of CHEMED Corporation’s past performance, current developments, and future prospects.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
